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Commentary
The authors have performed a beautiful study of transcranial 
magnetic stimulation (TMS) in the follicular and luteal phases 
of the menstrual cycles of a small group of healthy nonepi-
lepsy women (n = 20) and a much larger group of women with 
epilepsy (n = 171) and found some controversial results. Both 
groups were evaluated during either ovulatory or anovulatory 
cycles; it appears data were used for only one cycle per sub-
ject. The epilepsy group was divided into mutually exclusive 
multiple endocrinological and neurological categories: gener-
alized versus partial epilepsy, and type of catamenial seizure 
pattern (C1–3) if any and ovulatory versus anovulatory. Most of 
the epilepsy group were highly refractory, having on average 6 
seizures per month, with a minimum of 2 per month. However, 
a subset of the epilepsy group (n = 36) were seizure free for at 
least 1 year.
The findings presented in this study are counterintuitive 
according to current conceptions of reproductive neurosteroid 
activity yet extremely thought-provoking about brain excit-
ability in epilepsy assessed by TMS. The authors found no 
differences in cortical excitability when comparing ovulatory 
versus anovulatory cycles in any groups, including healthy 
nonepilepsy controls. This lack of difference therefore includes 
women who reported catamenial seizure patterns, women 
with seizures or without seizures and, most importantly, wom-
en with low, normal, or high estrogen or progesterone levels, 
depending on the ovulatory status for the cycle studied. The 
hormone levels reported were consistent with the ovulatory 
status; indeed, an anovulatory cycle was defined as a midluteal 
progesterone level of <5 ng/ml.
By way of background, TMS techniques such as central 
motor conduction time, the threshold and amplitude of motor 
evoked potentials allow the evaluation of motor conduction in 
the central nervous system. Advanced TMS applications used 
in epilepsy research include evaluation of brain excitability by 
deriving the cortical silent period length after motor stimula-
tion, as well as paired-pulse stimulation that allows assessment 
of intracortical facilitation, generally thought to be glutamate-
mediated activity, and intracortical inhibition, generally attrib-
uted to GABAA mediated-inhibition (1).
Reproductive hormones have little to do with TMS varia-
tion across the menstrual cycle according to these data. The 
authors have summarized previous studies nicely and present-
ed those results that differ from their own: Hattemer et al. in 
2006 reported an increase in excitability (decreased inhibition) 
Are Patterns of Cortical Hyper-Excitability Altered in Catamenial Epilepsy?
Badawy RA, Vogrin SJ, Lai A, Cook MJ. [published online ahead of print May 18, 2013]. Ann Neurol. doi: 10.1002/ana.23923.   
OBJECTIVE: We used transcranial magnetic stimulation to determine menstrual cycle-related changes in cortical excit-
ability in women with and without catamenial epilepsy and investigated whether these changes differed between 
ovulatory and anovulatory cohorts. METHODS: Healthy nonepilepsy women and women with generalized and focal 
epilepsy were investigated during ovulatory (n = 11, 46, and 43, respectively) and anovulatory (n = 9, 42, and 41) cycles. 
Patients were divided based on seizure pattern into catamenial (C1 = perimenstrual, C2 = periovulatory, C3 = luteal 
seizure exacerbation), noncatamenial, and seizure free. Cortical excitability was assessed using motor threshold (MT) 
and paired pulse stimulation at short (2-15 milliseconds) and long (100-300 milliseconds) interstimulus intervals twice, 
at the (1) late follicular and (2) mid luteal phases of the menstrual cycle. RESULTS: In controls, cortical excitability was 
greatest in the follicular study, where intracortical facilitation was increased (p < 0.05). The opposite was seen in women 
with epilepsy, where intracortical facilitation was greatest and intracortical inhibition was least in the luteal studies (p < 
0.05). There were no differences between the ovulatory and anovulatory groups in any of the cohorts. No changes were 
observed in MT. INTERPRETATION: Nonhormonal factors are involved in the cyclicity of cortical excitability across the 
menstrual cycle. Normal menstrual cycle variations in cortical excitability are altered in a similar pattern in ovulatory 
and anovulatory women with epilepsy regardless of seizure patterns. The underlying neural changes associated with 
epilepsy may alter responses to sex hormones. This may be an important underlying mechanism for catamenial seizure 
clustering.
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in the luteal phase as measured by TMS cortical silent period in 
5 women with catamenial epilepsy; however, there was much 
overlap with the results in the follicular phase (2). In another 
finding contrasting with the current study, Hattemer et al. in 
2007 did find differences in TMS parameters in a small number 
of healthy control women when comparing ovulatory versus 
anovulatory cycles (3). The authors acknowledge but do not 
explain these inconsistencies; one contributing reason may 
be that the investigators of the study under discussion did not 
perform cortical silent period assessment. However, the more 
important reason is that the current study is much larger than 
the previous studies, suggesting a Type 1 error in the previous 
work. Therefore, the results in more study subjects may bring 
us closer to the truth.
Intriguing findings are present here, though, indicating 
that TMS responses are altered due to having seizures in the 
setting of epilepsy, if not due to having ovulatory versus and 
anovulatory menstrual cycles. Healthy nonepilepsy women 
had increased cortical excitability evidenced by higher intra-
cortical facilitation in the follicular phase compared to the 
luteal phase; this finding now meets the bar of being repro-
ducible in that it was previously reported (4). One important 
finding in the current study is that in epilepsy patients, this 
gradient in cortical excitability is reversed: The luteal phase 
shows increased cortical excitability compared to the follicular 
phase. In fact, if one looks closely at the graphs of both the 
short and long interstimulus recovery curves for the epilepsy 
subjects, there is very little difference in responses when com-
paring phases of the menstrual cycle, as previously shown (2). 
Further observation of these graphs reveals that the responses 
in women with refractory epilepsy are very different than in 
control subjects. The responses in the long-term seizure-free 
group, however, are not dissimilar to controls. The graphs 
herein clearly show a luteal phase short response ISI curve in 
the seizure-free group not deviating from the normal curve, 
where as it is markedly increased from normal in all other epi-
lepsy groups. Since the authors state they have excluded anti-
epileptic drug (AED) effects by correlating AED type and levels 
with the responses, that leaves the epilepsy itself and seizure 
activity as possible causes of this finding. (These data are not 
shown, but the rest of the methodology is so painstaking that 
I tend to believe it.) This finding suggests  a “dose effect” of sei-
zures on TMS disruption, although the authors reported that 
in this study, seizure frequency had no effect on the results. In 
a slight contradiction of themselves, the lead authors’ previous 
work published this year shows that achieving seizure freedom 
with use of an AED decreases cortical excitability, indicating 
that seizure occurrence does play a role in the brain excitability 
parameters measured by TMS (5).
The authors’ previous work also shows that as measured 
by ISI, increased cortical excitability is present with new onset 
generalized epilepsy prior to treatment, with decreases in ex-
citability occurring with response to treatment (6). The seizure 
frequency in the new onset drug-naïve patients prior to TMS 
evaluation is unclear from this paper. In this work (6), motor 
threshold was lower in new onset drug-naïve subject while the 
motor threshold was higher in treatment responders; lower 
values indicate increased cortical excitability. Notably, no dif-
ferences in motor threshold were found across groups in the 
current study.
So, what conclusions can we draw from the plethora of 
information revealed by TMS studies in persons with epilepsy 
compared to controls? An attempt to summarize from avail-
able research follows.
1. There is some inconsistency in the TMS data across studies.
2. Consistent findings include:
a. Estrogen and progesterone levels and, in turn, ovula-
tory versus anovulatory cycles do not have an influence 
on TMS-measured cortical excitability.
b. Epilepsy patients in general have measurably different 
TMS responses than healthy nonepilepsy controls.
c. Effective treatment decreases TMS cortical excitability.
The question as to whether epilepsy itself produces TMS 
alterations that are significantly different from normal remains 
unclear from the available data and provides opportunity for 
further exploration.
by Cynthia L. Harden, MD
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